Phase III trial of tipelukast [MN 001; MediciNova] in patients with mild-to-moderate asthma
Latest Information Update: 21 Jan 2009
At a glance
- Drugs Tipelukast (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors MediciNova
- 20 Nov 2006 New trial record.